Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.15
Bid: 35.65
Ask: 35.95
Change: 2.65 (7.91%)
Spread: 0.30 (0.842%)
Open: 33.00
High: 36.15
Low: 33.00
Prev. Close: 33.50
IQE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IQE plc: H2 2020 Trading Update

24 Nov 2020 07:00

IQE plc: H2 2020 Trading Update

IQE plc

(“IQE” or the “Group”)

Trading Update

Cardiff, UK24 November 2020

IQE plc (AIM: IQE) the leading supplier of advanced wafer products and material solutions to the semiconductor industry, provides a trading update for the financial year ending 31 December 2020. 

Trading Update

After a record H1 2020 revenue performance, trading in the second half of the year has continued with positive momentum in both the Wireless and Photonics business units.

This has been evidenced by IQE receiving its largest Military & Defence sector purchase order to date from a major US customer, for both infrared and high-performance RF applications. With a combined value of more than US$10 million, the order will be deliverable over the next nine months.

Wireless Business Unit

Strong year-on-year growth in 2020 for the Wireless Business Unit has been driven by:

Demand for GaAs wafers for 5G handset power amplifiers fuelled by growing end market demand for ‘5G ready’ smartphones;Sales of GaN on SiC wafers for 5G infrastructure related to initial deployments of 5G base stations; andSales of high-performance GaN on SiC wafers for Military RF applications.

Photonics Business Unit

Strong year-on-year growth in 2020 for the Photonics Business Unit has been driven by:

Consistently high demand for GaAs VCSEL wafers for 3D sensing applications. IQE retains a market-leading position in 3D Sensing epitaxy and has been central to new applications being launched for this technology in its existing supply chains;Sales of high-performance GaSb wafers for Military & Defence infrared applications.

Full Year Outlook

IQE expects FY 2020 revenues to be at least £170m, exceeding the previous guidance of at least £165m, which was provided at the Interim Results on 8 September 2020. This equates to full year revenue growth of over 20%.

The Group anticipates delivering a mid-single-digit £m adjusted operating profit for FY20.

With a reduction in capital expenditure in FY20, along with a positive trading position and continued focus on cost control, net debt is anticipated to be low-single-digit £m. This represents a significant strengthening in the Group’s balance sheet position since the prior year end balance of £16m net debt.

The Group anticipates that underlying demand for the technologies that IQE’s products enable will remain strong heading into 2021. In particular, the Group expects demand for 5G-related products, both handset and infrastructure, will continue to grow over the next few years as the mega-replacement cycle of 5G deployments gathers pace around the world. In addition, IQE has a leading portfolio of Photonics products, for 3D Sensing and other applications, which makes the Group well-positioned for growth.

Dr Drew Nelson, Chief Executive Officer of IQE, said

“We are delighted to be reporting such a strong all-round financial performance, with anticipated revenue growth of over 20% for the full year, despite the ongoing uncertainty in the external environment. I am exceptionally proud of the whole IQE team whose dedication and commitment has enabled us to operate without interruption throughout this period.”

Contacts:

IQE plc+44 (0) 29 2083 9400Drew NelsonTim PullenAmy Barlow Peel Hunt LLP (Nomad and Joint Broker)+44 (0) 20 7418 8900Edward KnightPaul GillamNick Prowting Citigroup Global Markets Limited (Joint Broker)+44 (0) 20 7986 4000Christopher WrenPeter Catterall

Headland Consultancy (Financial PR) + 44 (0) 20 38054822Andy Rivett-Carnac: +44 (0) 7968 997 365Chloe Francklin: +44 (0)78 3497 4624

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/ 2014. For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of IQE by Tim Pullen, Chief Financial Officer of IQE.

GLOSSARYGaAs Gallium ArsenideGaN Gallium NitrideSiC Silicon CarbideVCSEL Vertical Cavity Surface Emitting Laser

ABOUT IQEhttp://iqep.com

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

handset devicesglobal telecoms infrastructureconnected devices3D Sensing

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the whole market and is agnostic to the winners and losers at chip and OEM level. By leveraging the Group’s intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with c. 650 employees across nine manufacturing locations in the UK, US, Taiwan and Singapore, and is listed on the AIM Stock Exchange in London.

Date   Source Headline
31st Jul 20064:07 pmRNSDirectors' Dealings
27th Jul 20062:47 pmRNSGrant of share options
20th Jul 20067:02 amRNSTrading Statement
20th Jul 20067:01 amRNSAcquisition
7th Jul 20062:46 pmRNSChange of Adviser
5th Jun 200610:32 amRNSDirector/PDMR Shareholding
30th May 20067:01 amRNSTrading Update
23rd May 200612:58 pmRNSAdditional Listing
19th May 20062:59 pmRNSHolding(s) in Company
8th May 20061:00 pmRNSAGM Notice & Board Appt
3rd May 20068:49 amRNSHolding(s) in Company
21st Apr 20066:01 pmRNSAdditional Listing
4th Apr 200612:45 pmRNSAdditional Listing
30th Mar 20064:25 pmRNSHolding(s) in Company
29th Mar 20061:51 pmRNSDirector/PDMR Shareholding
28th Mar 200611:27 amRNSHolding(s) in Company
20th Mar 20067:01 amRNSFinal Results
10th Mar 20064:33 pmRNSChange of Results Date
1st Mar 20067:01 amRNSNotice of Results
27th Jan 20067:01 amRNSContract Win
27th Jan 20067:01 amRNSPre-Close Trading Update
20th Dec 200511:58 amRNSAdditional Listing
26th Oct 20052:06 pmRNSHolding(s) in Company
20th Oct 20053:57 pmRNSDirector/PDMR Shareholding
10th Oct 20059:38 amRNSDirector/PDMR Shareholding
12th Sep 20053:09 pmRNSHolding(s) in Company
24th Aug 20057:00 amRNSInterim Results
19th Aug 200511:46 amRNSAdditional Listing
29th Jul 20057:00 amRNSNotice of Results
22nd Jul 20055:23 pmRNSHolding(s) in Company
20th Jul 20051:17 pmRNSHolding(s) in Company
19th Jul 200510:42 amRNSHolding(s) in Company
18th Jul 20053:52 pmRNSHolding(s) in Company
15th Jul 200512:54 pmRNSAdditional Listing
12th Jul 20057:30 amRNSIndustry Award Win
28th Jun 200511:47 amRNSAdditional Listing- Replace
28th Jun 200510:12 amRNSAdditional Listing
17th Jun 20059:48 amRNSHolding(s) in Company
16th Jun 200511:09 amRNSHolding(s) in Company
26th May 200511:53 amRNSAnnual Report and Accounts
25th May 20051:15 pmRNSAGM Statement
18th Apr 20053:24 pmRNSAdditional Listing
22nd Mar 20057:02 amRNSFinal Results
28th Feb 20059:33 amRNSNotice of Results
4th Feb 20051:18 pmRNSHolding(s) in Company
27th Jan 20057:00 amRNSTrading Statement
10th Jan 200511:35 amRNSAdd. Listing/Director s/hldng

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.